Anzeige
Mehr »
Login
Montag, 27.01.2025 Börsentäglich über 12.000 News von 683 internationalen Medien
Hinter dem nuklearen Ansturm im Silicon Valley: Eine strategische Chance entsteht
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
242 Leser
Artikel bewerten:
(1)

GreenBank Capital Inc.: GreenBank Capital Completes Purchase of Significant Stake in Flex Capital, a Fintech Company Designed to Provide Transparency to Financial Donors Across a Variety of Community Engagements

Finanznachrichten News

This news release is not for distribution or dissemination in the United States of America

TORONTO, ON / ACCESSWIRE / April 7, 2021 / GreenBank Capital Inc. (CSE:GBC)(OTC PINK:GRNBF)(FRA:2TL) ("GreenBank" or "the Company") is pleased to announce that it has completed the purchase of a 25% shareholding in Flex Capital ("Flex") pursuant to GreenBank's announcement on 11th March 2021. Flex Capital is producer of the Eflex app, designed to radically improve transaction transparency for people donating money across a variety of industries and encourage communities of donors to communicate together and develop, from football clubs to charities and everything in between.

The charity sector, for example, receives many tens of billions of dollars of donations per annum worldwide, but the level of transparency in how the money is spent is minimal, and the related gratification a donor receives - as a result of not knowing how the money they donated has tangibly helped - is therefore correspondingly small.

In contrast, if a donor knows that the money they have donated is helping a specific good cause and can actually see the manner in which their specific contribution is deployed, the level of donor gratification - and therefore willingness to help more - radically increases. The Eflex app not only provides that level of transparency, but also encourages communities of donors to develop as like-minded people see their collective donations at work, which in turn can help promote the good cause by encouraging others to join.

This level of engagement and the propensity for greater donor or membership support is expected by Eflex to be a key consideration for charity, group and community leaders as they seek to benefit from the greater support that comes from deeper engagement, and is a principal reason why Eflex is expecting strong demand for the app when it is scheduled to go live later in 2021.

Eflex is expected to generate revenue by charging a transaction fee from each transaction processed through the app and by providing service support where needed. Total transactions are expected by Eflex to eventually exceed C$1bn per annum.

Eflex have agreed to use the Zeu Technogies (CSE:ZeU) "ZeUpay" payment system. Zeu is listed on the Canadian Securities Exchange and is partly owned by St-Georges, a company in which GreenBank Capital has a substantial investment. www.ZeUniverse.com.

GreenBank has the right to appoint a member to board of Flex and it has been agreed that GreenBank will (as well as having a right of first refusal on any subsequent equity issues) act as a lead advisor in any further financing and on taking Flex to a public listing.

Arnar Gunnarsson, Flex Capital CEO commented, "It is very exciting for the Eflex team to be recognized by GreenBank in this way - they clearly see the potential for our product and the market-need for our unique approach and solution whilst sharing the same vision for increasing the breadth of the business and accelerating our growth."

David Lonsdale, GreenBank CEO said, "We are thrilled to be teaming up with Eflex as they seek to make the business of giving so much more rewarding, not just for the charity or club, but also for the supporter. This is the model of "giving for the future", and we believe demand for this app could be very large indeed."

About GreenBank

GreenBank is a next generation merchant banking business that has a flexible low-cost overhead structure designed to maximize profitability. Our management are based in Toronto, Dallas, New York and London and are used to working across borders remotely. Our model of remote working, dynamic space and flexible contracts -rather than expensive offices, and large fixed costs - establishes GreenBank as a global merchant bank for the future, both during and after COVID19.

GreenBank is listed on the Canadian Securities Exchange, the Frankfurt Boerse and on the OTC Markets in the USA. GreenBank invests in undervalued exponential growth companies focused on building consistent capital appreciation for its shareholders.

For details of our "6 Key Drivers of Value" please see our latest Investor Presentation:

https://greenbankcapitalinc.com/wp-content/uploads/2020/11/03.11.20_Greenbank-Deck-compressed.pdf

For more information please visit our website www.GreenBankCapitalInc.com or contact

Mark Wettreich at +1 (647) 693 9411 or by email Mark@GreenBankCapitalinc.com

SOURCE: GreenBank Capital Inc.



View source version on accesswire.com:
https://www.accesswire.com/639276/GreenBank-Capital-Completes-Purchase-of-Significant-Stake-in-Flex-Capital-a-Fintech-Company-Designed-to-Provide-Transparency-to-Financial-Donors-Across-a-Variety-of-Community-Engagements

© 2021 ACCESS Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.